Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
The type of microbiome that repopulates the gut after antibiotics has the potential to reprogram the mammalian immune system with long-lasting effects including on longevity. A new study published in…
Chemotherapy treatment and intestinal diseases can alter the process of programmed cell death, which can lead to gastrointestinal tract's infections.
Specific changes in the gut microbiota could contribute to disruptions in brain physiology and cognitive behavior. This process leads to cognitive impairment. A new study published in Cell Host &…
The ability to transfer resistance to infection suggests that the microbiota could be harnessed for therapeutic treatments. A new study published in Cell Reports claims.
A new study published in Cell Host & Microbe suggests that the transfer of gut microbes from a mother to her offsprin could reduce the risk of developing type 1…
A new study suggests that gut microbes could affect stroke severity or post-stroke outcome through a metabolite called TMAO.
Researchers have developed a new approach to study microbial metabolism that works by detecting microbial metabolites in diverse biological samples and trace them back to the metabolic profiles of bacteria…
New findings suggest that fermented foods can help countering the decreased microbiota diversity and heightened inflammation that characterize industrialized populations.
A study published in Nature Medicine claims that the manipulation of the gut microbiota could be a new strategy to treat toxicity to combined immunotherapy.
Fecal microbiota transplants combined with daily fiber supplement improves insulin sensitivity in obese individuals with metabolic syndrome.
